Outstanding Questions to Understand and Target Splicing Factor–Mutant Blood Cancers

Read full text
Authors: Maxim I. Maron, Omar Ibrahim Abdel-Wahab
Cited by: 1
References: 15

Abstract

Mutations in genes encoding RNA splicing factors are common in patients with myeloid malignancies and chronic lymphocytic leukemia. In this commentary, we discuss key unanswered questions on the causal role of these mutations in blood cancers and precursor conditions as well as efforts to develop therapies targeting these high-frequency neomorphic mutations.

Fields of Study & Subjects

RNA Research and Splicing Acute Myeloid Leukemia Research Nuclear Structure and Function

Publication details

Journal / source
Blood Cancer Discovery
Publisher
American Association for Cancer Research (AACR)
Volume
7
Issue
3
Pages
348–352
Publication date
21 April 2026
Language
EN